Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Despropionylfentanyl (substance) |
Is a |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl citrate |
Is a |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
methyfentanyl |
Is a |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl measurement |
Component |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 1.6 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 1.2 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 800 microgram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 600 microgram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 400 microgram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl 200 microgram oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl poisoning (disorder) |
Causative agent |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Accidental fentanyl poisoning |
Causative agent |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Intentional fentanyl poisoning |
Causative agent |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
forgiftning med fentanyl, uvist med hvilken hensigt |
Causative agent |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl adverse reaction |
Causative agent |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Allergy to fentanyl (finding) |
Causative agent |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl overdose |
Causative agent |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Accidental fentanyl overdose |
Causative agent |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Intentional fentanyl overdose |
Causative agent |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
overdosis af fentanyl, uvist med hvilken hensigt |
Causative agent |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
fentanyl 25 µg/time depotplaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
fentanyl 50 µg/time depotplaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
fentanyl 75 µg/time depotplaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
fentanyl 100 µg/time depotplaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
fentanyl 50 µg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
fentanyl 50 µg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing droperidol and fentanyl (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 300 microgram oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing fentanyl (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
bupivacainhydrochlorid + fentanyl |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + fentanyl 0,1%/2µg/mL injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl 12 microgram/hour prolonged-release transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Accidental fentanyl poisoning |
Causative agent |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Intentional fentanyl poisoning |
Causative agent |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
fentanyl 40 µg + aktivering iontoforetisk transdermalt system |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl 100 microgram buccal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl 400 microgram buccal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 800 microgram/1 each conventional release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl dependence (disorder) |
Causative agent |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 400 microgram buccal film |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal film (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal film (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 1.2 milligram/1 each conventional release buccal film (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Fentanyl 800 microgram buccal film |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Allergy to fentanyl (finding) |
Causative agent |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
2 |
Fentanyl citrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
|
methyfentanyl |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Despropionylfentanyl (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
|
Product containing fentanyl in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl (as fentanyl citrate) 100 microgram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl (as fentanyl citrate) 500 microgram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing fentanyl in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing only droperidol and fentanyl (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing only fentanyl (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing only fentanyl in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Allergy to fentanyl (finding) |
Causative agent |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl (as fentanyl citrate) 50 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 1.2 milligram/1 each conventional release buccal film (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 1.2 milligram/1 each conventional release buccal film (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 800 microgram buccal film |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 800 microgram buccal film |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 400 microgram buccal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 400 microgram buccal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 300 microgram buccal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 300 microgram buccal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 400 microgram buccal film |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 400 microgram buccal film |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal film (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal film (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal film (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal film (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 800 microgram/1 each conventional release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 800 microgram/1 each conventional release buccal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 100 microgram buccal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 100 microgram buccal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 1.6 mg oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 1.6 mg oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 300 microgram oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Fentanyl 300 microgram oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 1.2 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 1.2 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 800 microgram/1 each conventional release oromucosal lozenge (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 800 microgram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 600 microgram/1 each conventional release oromucosal lozenge (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 600 microgram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl 400 microgram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fentanyl (substance) |
Inferred relationship |
Some |
1 |